Skip to main content

Integrated Hepatitis Testing: What's New in Viral Hepatitis Diagnosis and Management?

Tracking # 20-1332949

Price not reported

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Broadcasted Interactive Event
Dates Contact provider

Course overview

This session highlights the laboratory's essential role in addressing the global burden of hepatitis B and C. Attendees will examine current epidemiological trends, key diagnostic challenges, and evidence-based testing strategies. The session will emphasize integrated testing algorithms and advanced virological tools that support early detection, accurate diagnosis, and effective disease management across both developed settings and high-risk or underserved populations.

Subject areas

This course counts toward the state boards and subject areas below.

American Board of Clinical Chemistry

Clinical Chemistry Diplomate

1h Category 1

Molecular Diagnostics Diplomate

1h Category 1

Toxicological Chemistry Diplomate

1h Category 1

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

1h General

Clinical Laboratory Supervisor

1h General

Clinical Laboratory Technician

1h General

Clinical Laboratory Technologist

1h General

Public Health Director

1h General

Public Health Supervisor

1h General

Public Health Technologist

1h General

Disclosure statements

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.


The following faculty reported financial relationships:


  • Stephane Chevaliez, PharmD-Ph.D
  • Honorarium/Expenses: Gilead Sciences
  • Consulting Fees: Roche and Abbvie